Home › Non-Muscle Invasive Bladder Cancer › Ohio › Columbus
Non-Muscle Invasive Bladder Cancer clinical trials in Columbus, OH
10 studies for Non-Muscle Invasive Bladder Cancer are looking for participants at sites in and around Columbus (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
RecruitingPhase 3
- Ohio State University Comprehensive Cancer Center, Columbus
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
RecruitingPhase 2
- The James at Brain and Spine Hospital (OSU), Columbus
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
RecruitingPhase 3
- Central Ohio Urology Group, Gahanna · 7 mi away
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
RecruitingPhase 1
- The Ohio State University (OSU), Columbus
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
RecruitingPhase 1/2
- Central Ohio Urology Group, Gahanna · 7 mi away
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
RecruitingObservational study
- The Ohio State University, Columbus
A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
RecruitingPhase 1/2
- The Ohio State University, Columbus
Studying the Relationship of Patient Positioning and Intravesical Bacillus Calmette Guerin Dwell Time to Improve the Treatment of Non-muscle Invasive Bladder Cancer
RecruitingPhase 4
- Ohio State University Comprehensive Cancer Center, Columbus
Blue Light Cystoscopy With Cysview® Registry
RecruitingObservational study
- Ohio State University Wexner Medical Center, Columbus
- Ohio State University, Columbus
Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients
RecruitingPhase 2
- Site 02-017 - Central Ohio Urology Group, Gahanna · 7 mi away
Non-Muscle Invasive Bladder Cancer trials in other cities
- Dallas, TX10 studies
- New York City, NY10 studies
- Myrtle Beach, SC9 studies
- Edison, NJ9 studies
- Baltimore, MD8 studies
- Syracuse, NY8 studies
- Nashville, TN8 studies
- Houston, TX7 studies
- Indianapolis, IN7 studies
- Philadelphia, PA7 studies
- Birmingham, AL7 studies
- Atlanta, GA7 studies
Other studies in Columbus
- Non-Small Cell Lung Cancer57 studies
- Breast Cancer40 studies
- Ovarian Cancer39 studies
- Cancer (all types)38 studies
- Lung Cancer37 studies
- Acute Myeloid Leukemia35 studies
- Chronic Lymphocytic Leukemia28 studies
- Metastatic Cancer27 studies
- Endometrial Cancer25 studies
- Prostate Cancer24 studies
- Multiple Myeloma24 studies
- Colorectal Cancer24 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.